Tibet AIM Pharm. Inc. (SHE:002826)

Tibet AIM Pharm. Revenue

Tibet AIM Pharm. had revenue of 182.58M CNY in the quarter ending March 31, 2026, with 22.92% growth. This brings the company's revenue in the last twelve months to 670.32M, up 4.74% year-over-year. In the year 2025, Tibet AIM Pharm. had annual revenue of 636.27M, down -2.39%.

• Revenue (ttm): 670.32M
• Revenue Growth: +4.74%
• P/S Ratio: 4.30
• Revenue / Employee: 1.66M
• Employees: 405
• Market Cap: 2.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	636.27M	-15.61M	-2.39%
Dec 31, 2024	651.88M	-15.16M	-2.27%
Dec 31, 2023	667.04M	-189.70M	-22.14%
Jan 1, 2023	856.73M	131.28M	18.10%
Jan 1, 2022	725.46M	122.84M	20.38%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error